Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
about
Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)Efficacy and Safety of COX-2 Inhibitors in the Clinical Management of Arthritis: Mini ReviewEffect of formulation variables on preparation of celecoxib loaded polylactide-co-glycolide nanoparticlesDrug Targets for Cardiovascular-Safe Anti-Inflammatory: In Silico Rational Drug StudiesThe nociceptive and anti-nociceptive effects of bee venom injection and therapy: a double-edged swordTrihydroxyflavones with antioxidant and anti-inflammatory efficacy.Exploration of binding site pattern in arachidonic acid metabolizing enzymes, Cyclooxygenases and Lipoxygenases.The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research.Anti-inflammatory effect of patchouli alcohol isolated from Pogostemonis Herba in LPS-stimulated RAW264.7 macrophages.Cysteinyl leukotrienes mediate the enhancing effects of indomethacin and aspirin on eosinophil production in murine bone marrow cultures.Major role of adipocyte prostaglandin E2 in lipolysis-induced macrophage recruitmentJNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittinEvaluation of the molecular mechanisms associated with cytotoxicity and inflammation after pulmonary exposure to different metal-rich welding particlesPEP-1-FK506BP inhibits alkali burn-induced corneal inflammation on the rat model of corneal alkali injury.Activity and potential role of licofelone in the management of osteoarthritis.Sex differences in innate immunity and its impact on opioid pharmacology.PEP-1-PON1 protein regulates inflammatory response in raw 264.7 macrophages and ameliorates inflammation in a TPA-induced animal model.Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor traffickingRecent developments in the inhibitors of neuroinflammation and neurodegeneration: inflammatory oxidative enzymes as a drug target.Dual inhibition: a novel promising pharmacological approach for different disease conditions.Drug-drug interaction between NSAIDS and low-dose aspirin: a focus on cardiovascular and GI toxicity.Alterations of tendons in diabetes mellitus: what are the current findings?Celecoxib, a COX-2 inhibitor, synergistically potentiates the anti-inflammatory activity of docosahexaenoic acid in macrophage cell line.Homoisoflavanone prevents mast cell activation and allergic responses by inhibition of Syk signaling pathway.Overexpression of Annexin A1 Suppresses Pro-Inflammatory Factors in PC12 Cells Induced by 1-Methyl-4-Phenylpyridinium.Tomatidine inhibits iNOS and COX-2 through suppression of NF-kappaB and JNK pathways in LPS-stimulated mouse macrophages.Non-steroidal anti-inflammatory drugs in athletes.Effects of zileuton and montelukast in mouse experimental spinal cord injury.Synthesis, analgesic, anti-inflammatory and in vitro antimicrobial activities of some novel isoxazole coupled quinazolin-4(3H)-one derivatives.Genetic and Histological Alterations Reveal Key Role of Prostaglandin Synthase and Cyclooxygenase 1 and 2 in Traumatic Brain Injury-Induced Neuroinflammation in the Cerebral Cortex of Rats Exposed to Moderate Fluid Percussion Injury.Tacrolimus and nonsteroidal anti-inflammatory drugs: an association to be avoided.Glycyrrhizin ameliorates metabolic syndrome-induced liver damage in experimental rat model.An ethnopharmacological study of medicinal plants in New South Wales.Protective effect of aspirin treatment on mouse behavior in the acute phase of experimental infection with Trypanosoma cruzi.Nucleophosmin modulates the alleviation of atopic dermatitis caused by the marine-derived compound dihydroaustrasulfone alcohol.Synthesis of tert-butyl (substituted benzamido)phenylcarbamate derivatives: anti-inflammatory activity and docking studies.2,3-Diarylxanthones as Potential Inhibitors of Arachidonic Acid Metabolic Pathways.
P2860
Q24186403-54B90BE0-A291-4D57-ADB7-EB33D8CE1529Q24201300-37A2D058-9A27-4B6A-8233-3D6E67888F7EQ24634894-CC2F0D83-24B7-4BBD-8FFB-CCEE89BAB53CQ28542696-D716379C-B1B2-427A-95DD-7E10020F7787Q28552684-7559DF45-9188-4F81-9807-34E0C0254CD3Q34157706-F3874432-9CF2-41DD-97B5-EB705AF45133Q34288780-80B46C59-4F06-4EEB-BF49-C4982250211EQ35559135-12145D2D-F8A6-45CA-8673-56A93E51812CQ36048230-60DF6E12-70A0-4188-9921-3017916BE4AAQ36230620-7F24E94B-06FA-49B8-84F2-359B6C1F1623Q36456881-82319C5A-4211-4DE1-A2A9-25479296793BQ36731781-32B0EED8-6AA1-4F26-8805-10D1A343F4A8Q36742151-2B99E3C3-9D41-4D78-8035-8B44935804E6Q36887844-B988F3ED-BB02-4865-A45B-27669377E7D7Q37013879-F307D091-45A0-4163-8D14-807754F10903Q37017276-53468F9D-8CA0-436F-AAE9-28E65E5E6D74Q37432134-2253D441-B97A-41A5-852F-D4B969CB07FDQ37509810-523AA451-061E-4D8B-8406-1C536F4857CEQ37794776-E2EFE4EE-DA9C-405C-972B-637062DF1A68Q37799603-B6D2102B-A83E-4F06-A2D9-FB2436B12332Q37852762-AAA71AF2-9F10-46E4-9144-61C28EB47235Q38218184-D32F60F2-38CF-463F-BF8F-D48C2B1C6353Q38461078-8017107D-9496-4A81-8E84-33509B3E97BBQ38787940-B81E45EF-302D-4188-A952-AB9A5FD6D5D6Q39032424-A75B8057-9E1F-4CEF-A9EE-977BFD5DA65FQ39474445-5DDCF5B3-B404-4155-A2FD-0DB74215A24FQ39973470-C47FDD00-8BCF-4A75-BA2A-45ACE6DAF5BCQ42233641-56003544-2BEF-44C3-9C69-8E617637D4C3Q43042658-7721A5DA-F2B3-41EA-8C4E-DA7C41EED7E7Q45012933-E5E043A8-50CB-4332-A6EF-9B8662D101E2Q46408703-22760A95-DB33-478A-B1DA-CFE0CD0A0877Q46565086-8CD58E0F-9708-48CC-8A0E-D34452B4495FQ46665032-F2DCA987-837E-46CC-93FD-722D3BF98EF3Q46896671-7954F5AA-644A-487C-B088-D13DD4AD461DQ47381302-23A59AA4-8484-4DBF-85F1-91B7184FE832Q52367519-7C6B088F-1958-4212-B47D-DB7AE1487532Q53175263-AE8637FA-B05A-42BC-8A38-6289838AEDCAQ53442598-F14B2CF0-618E-45D6-B01B-A9CAECF26B05
P2860
Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
@ast
Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
@en
type
label
Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
@ast
Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
@en
prefLabel
Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
@ast
Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
@en
P2093
P356
P1476
Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
@en
P2093
P304
P356
10.2174/0929867024606650
P577
2002-05-01T00:00:00Z